Literature DB >> 15832138

Is operative blood loss associated with valproic acid? Analysis of bilateral femoral osteotomy in children with total involvement cerebral palsy.

Brian T Carney1, Christin L Minter.   

Abstract

Valproic acid (VPA) may increase surgical bleeding. The purpose of this study was to review the effect of VPA on blood loss during bilateral femoral osteotomy in children with cerebral palsy. The medical records of 29 children were retrospectively reviewed. Blood volume, total blood loss, and postoperative blood loss were calculated. Fourteen children were taking no anticonvulsant medications, nine children were taking anticonvulsant medications other than VPA, and six children were taking anticonvulsant medications including VPA. The group taking anticonvulsant medications including VPA had significantly lower preoperative platelet counts (204,000) and a significantly greater incidence of transfusion (50%). Compared with the group taking no anticonvulsant medications, the group taking anticonvulsant medications including VPA had a significantly greater change in hematocrit and greater blood loss. Blood loss and the need for transfusion should be anticipated for in children with cerebral palsy taking VPA who undergo femoral osteotomy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832138     DOI: 10.1097/01.bpo.0000152942.95239.b1

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  2 in total

1.  Blood Loss and Related Laboratory Changes after Single-Event Multilevel Surgery and Hip Reconstructive Surgery in Patients with Cerebral Palsy.

Authors:  Jae Jung Min; Soon-Sun Kwon; Kyu Tae Kim; Ki Hyuk Sung; Kyoung Min Lee; Young Choi; Moon Seok Park
Journal:  Clin Orthop Surg       Date:  2021-06-03

2.  The Value of Tranexamic Acid in Reducing Blood Loss following Hip Reconstruction in Children with Cerebral Palsy.

Authors:  I Majid; S Alshryda; B Somanchi; E Morakis; A Foster
Journal:  J Blood Transfus       Date:  2015-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.